SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

Federal funding opportunity PAR-27-098 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes April 5, 2029

Program funding history

Synopsis

Who can apply

• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• County governments
• Native American tribal governments (Federally recognized)
• City or township governments
• Public and State controlled institutions of higher education
• Special district governments
• Private institutions of higher education
• For profit organizations other than small businesses
• Native American tribal organizations (other than Federally recognized tribal governments)
• State governments
• Public housing authorities/Indian housing authorities
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Independent school districts
• Small businesses

Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

How to apply

Similar grants

• Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  FOR-CA-25-086 · National Institutes of Health
• NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
  PA-27-101 · National Institutes of Health · closes April 5, 2029
• Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
  PAR-25-450 · National Institutes of Health · closes July 20, 2028
• Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
  PAR-25-206 · National Institutes of Health · closes January 7, 2028
• Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
  PAR-25-284 · National Institutes of Health · closes January 7, 2028
• Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
  PAR-25-122 · National Institutes of Health · closes November 16, 2027